Alcon - ALC Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALC, but not buy additional shares or sell existing shares.
View ALC analyst ratings or view top-rated stocks.

9 equities research analysts have issued twelve-month price objectives for Alcon's stock. Their ALC share price forecasts range from $68.80 to $92.00. On average, they anticipate the company's stock price to reach $79.80 in the next year. This suggests a possible upside of 22.0% from the stock's current price.
View analysts price targets for ALC or view top-rated stocks among Wall Street analysts.

Alcon's stock was trading at $68.55 on January 1st, 2023. Since then, ALC stock has decreased by 4.6% and is now trading at $65.40.
View the best growth stocks for 2023 here.

Alcon saw a drop in short interest during the month of February. As of February 28th, there was short interest totaling 5,720,000 shares, a drop of 5.9% from the February 13th total of 6,080,000 shares. Based on an average daily trading volume, of 846,700 shares, the days-to-cover ratio is currently 6.8 days. Currently, 1.2% of the shares of the stock are short sold.
View Alcon's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our ALC earnings forecast.

Alcon Inc. (NYSE:ALC) released its earnings results on Monday, February, 27th. The healthcare company reported $0.42 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.42. The healthcare company earned $2.17 billion during the quarter, compared to analysts' expectations of $2.14 billion. Alcon had a net margin of 3.84% and a trailing twelve-month return on equity of 5.66%.

Alcon announced a dividend on Saturday, April 23rd. Investors of record on Monday, May 2nd will be paid a dividend of $0.13 per share on Tuesday, May 3rd. This represents a yield of 0.18%. The ex-dividend date is Friday, April 29th.
Read our dividend analysis for ALC.

Alcon updated its FY23 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of $2.55-2.65 for the period, compared to the consensus earnings per share estimate of $2.54. The company issued revenue guidance of $9.2-9.4 billion, compared to the consensus revenue estimate of $9.26 billion.

6 employees have rated Alcon Chief Executive Officer Greg D. Wight on Glassdoor.com. Greg D. Wight has an approval rating of 100% among the company's employees. This puts Greg D. Wight in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), International Business Machines (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and AbbVie (ABBV).

Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."

Alcon's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Credit Suisse AG (2.68%), Norges Bank (2.39%), Clearbridge Investments LLC (2.09%), Zurcher Kantonalbank Zurich Cantonalbank (1.49%), T. Rowe Price Investment Management Inc. (1.30%) and Brown Brothers Harriman & Co. (1.15%).

Shares of ALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALC stock can currently be purchased for approximately $65.40.

Alcon (NYSE:ALC) has a market capitalization of $32.05 billion and generates $8.72 billion in revenue each year. The healthcare company earns $335 million in net income (profit) each year or $0.67 on an earnings per share basis.

The company employs 25,000 workers across the globe.

Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The official website for the company is www.alcon.com. The healthcare company can be reached via phone at 418172930450, via email at investor.relations@alcon.com, or via fax at 41-58-911-3222.